Clinical Trials Directory

Trials / Unknown

UnknownNCT04276389

OCT- Versus Angiography-guided Paclitaxel Drug-Coated Balloon Angioplasty in De Novo Coronary Artery

OCT- Versus Angiography-guided Paclitaxel Drug-Coated Balloon Angioplasty in De Novo Coronary Artery After Lesion Preparation With Scoring Balloon - A Prospective Multicenter Cohort Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Beijing Anzhen Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

OCT allows precise evaluation of intimal injury after lesion preparation and may improve the acute results and long-term outcomes after paclitaxel drug-coated balloon angioplasty. This prospective multicenter cohort study aims to assess the efficacy and safety of OCT- versus angiography-guided paclitaxel drug-coated balloon angioplasty in middle-sized de novo coronary artery after lesion preparation with scoring balloon.

Conditions

Interventions

TypeNameDescription
DEVICEOCT-guided paclitaxel drug-coated balloon angioplastyOCT-guided paclitaxel drug-coated balloon angioplasty in middle-sized de novo coronary artery
DEVICEAngiography-guided paclitaxel drug-coated balloon angioplastyAngiography-guided paclitaxel drug-coated balloon angioplasty in middle-sized de novo coronary artery

Timeline

Start date
2017-08-01
Primary completion
2020-08-31
Completion
2020-08-31
First posted
2020-02-19
Last updated
2020-02-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04276389. Inclusion in this directory is not an endorsement.